CR-discovered NXP800 shows promise in clinical trials

Groundbreaking approval provides new hope for patients in England and Wales

New FDA-approved schizophrenia treatment shows promise in clinical trials

Investment to support RNA therapeutics for epilepsy and neurological disorders

OAV101 IT expands potential for type II SMA patients

M-Trust set to improve product safety and counterfeiting solutions

EpiSwitch PSE shows promise in reducing unnecessary procedures

IMDYLLTRA offers new hope for patients with extensive-stage small cell lung cancer

Government announces independent commission on social care